Attached files
| file | filename |
|---|---|
| EX-31.2 - EXHIBIT 31.2 - NEXEON MEDSYSTEMS INC | ex31_2.htm |
| EX-31.1 - EXHIBIT 31.1 - NEXEON MEDSYSTEMS INC | ex31_1.htm |
| 10-Q - NEXEON MEDSYSTEMS INC | n5517010q.htm |
EXHIBIT 32.1
CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Nexeon MedSystems Inc (the “Company”) on Form 10-Q for the three-month period ended March 31, 2017, filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned officers of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of our knowledge:
|
|
(1)
|
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|
|
|
(2)
|
The information contained in the Report fairly presents, in material respects, the financial condition and results of operations of the Company, as of, and for the periods presented in the Report.
|
|
Date: May 9, 2017
|
|
|
|
/s/ William Rosellini
|
|
|
William Rosellini
Chief Executive Officer
|
|
|
|
|
|
|
|
|
/s/ Christopher R. Miller
|
|
|
Christopher R. Miller
Chief Financial Officer
|